Skip to content
Bored Studies
RecruitingAccepts healthy volunteersPhase 1

A Study of V132 in Healthy Older Participants (V132-001)

Merck Sharp & Dohme LLC · NCT07712575

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 50–75 · All sexes
Healthy volunteers
Accepted
Study type
Interventional · Phase 1
Target enrollment
280
US sites recruiting
10
Study start
August 12, 2026
Record last updated
October 20, 2026

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

The goal of this study is to learn about the safety and immune response to the V132 vaccine in healthy older adults.

Being studied: V132 Formulation 1; V132 Formulation 2; V132 Formulation 3; PREVNAR 20™; CAPVAXIVE™

Conditions: Healthy

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Inclusion Criteria

The key inclusion criteria include but are not limited to the following:

  • Is in good health
  • Has body mass index (BMI) within 18.0 to 35.0 kg/m\^2 (inclusive)

Exclusion Criteria

The key exclusion criteria include but are not limited to the following:

  • Has a history of invasive pneumococcal disease or known history of other culture-positive pneumococcal disease within 3 years prior to receiving study vaccination
  • Has received a pneumococcal polysaccharide vaccine in the previous 10 years, has received any pneumococcal conjugate vaccine at any time prior to this study

Recruiting US locations

  • Anaheim Clinical Trials ( Site 0006)

    Anaheim, CA 92801

    Site contact: Study Coordinator · 714-774-7777

  • Velocity Clinical Research, Hallandale Beach ( Site 0003)

    Hallandale, FL 33009

    Site contact: Study Coordinator · 954-455-5757

  • Research Centers of America ( Hollywood ) ( Site 0009)

    Hollywood, FL 33024

    Site contact: Study Coordinator · 954-990-7649

  • QPS-MRA, LLC-Early Phase ( Site 0001)

    South Miami, FL 33143

    Site contact: Study Coordinator · 305-722-0970

  • Bio-Kinetic Clinical Applications, LLC dba QPS-MO ( Site 0002)

    Springfield, MO 65802

    Site contact: Study Coordinator · 417-831-2048

  • Velocity Clinical Research Lincoln ( Site 0007)

    Lincoln, NE 68510

    Site contact: Study Coordinator · 531-530-2800

  • Velocity Clinical Research, Omaha ( Site 0008)

    Omaha, NE 68134

    Site contact: Study Coordinator · 402-933-6500

  • Remington-Davis, Inc. ( Site 0005)

    Columbus, OH 43215

    Site contact: Study Coordinator · 614-487-2560

  • Velocity Clinical Research, Providence ( Site 0010)

    East Greenwich, RI 02818

    Site contact: Study Coordinator · 401-739-9350

  • University of Texas Medical Branch ( Site 0004)

    League City, TX 77573

    Site contact: Study Coordinator · 832-340-2313

Study contacts (from the official record)

  • Toll Free Number · 1-888-577-8839 · Trialsites@msd.com
All healthy volunteers studies in California →